3M's Consumer Unit Hurt by Weak Demand: What's the Road Ahead? — Neutral
MMM Zacks Investment Research — August 25, 2025MMM faces weak consumer demand and muted retail restocking, but its Safety and Industrial segment shows solid growth momentum.
Can The Trade Desk's CTV Momentum Fend Off Rising Competition? — Positive
TTD Zacks Investment Research — August 25, 2025TTD's CTV momentum, fueled by Kokai adoption and live sports targeting, faces stiff competition from rivals like Magnite and PubMatic.
Walmart E-Commerce Soars 25% Globally: How Big Can Digital Get? — Positive
WMT Zacks Investment Research — August 25, 2025WMT's Q2 e-commerce sales soar 25% globally, driven by faster fulfillment, marketplace growth and rising membership income.
Will Boeing's Commercial Aircraft Division Maintain Its Altitude? — Positive
BA Zacks Investment Research — August 25, 2025BA's commercial jet unit surges with rising 737 deliveries, major global orders and a robust backlog, fueling revenue growth.
CBOE Stock Rises 26.1% YTD: A Signal for Investors to Hold Tight? — Positive
CBOE Zacks Investment Research — August 25, 2025Cboe Global drives growth with diversified revenues, global expansion, and Data Vantage fee gains, supported by a strong balance sheet and strategic buyouts.
Analyst Predicts "Inflection Point" for OKTA: Bullish Cybersecurity Outlook Remains — Positive
OKTA Schwab Network — August 25, 2025Truist upgraded Okta Inc. (OKTA) and raised its price target for the cybersecurity company ahead of its earnings report on Tuesday. Sam Vadas talks about the optimism surrounding cybersecurity's long-term case, even with Okta's stock down year-over-year.
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Nutex Health Inc. (NUTX) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm — Neutral
NUTX GlobeNewsWire — August 25, 2025ATLANTA, Aug. 25, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material adverse information regarding Nutex's business, operations, and prospects, including allegations that: (i) HaloMD was achieving lucrative arbitration results for Nutex by engaging in a coordinated scheme to defraud insurance companies; (ii) as a result, to the extent that they were the product of fraudulent conduct, revenues attributable to Nutex's engagement with HaloMD in the IDR process were unsustainable; (iii) …
Wall Street Analysts Predict a 29.62% Upside in Hesai Group Sponsored ADR (HSAI): Here's What You Should Know — Positive
HSAI Zacks Investment Research — August 25, 2025The average of price targets set by Wall Street analysts indicates a potential upside of 29.6% in Hesai Group Sponsored ADR (HSAI). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
How Much Upside is Left in InfuSystems Holdings (INFU)? Wall Street Analysts Think 41.07% — Positive
INFU Zacks Investment Research — August 25, 2025The average of price targets set by Wall Street analysts indicates a potential upside of 41.1% in InfuSystems Holdings (INFU). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Backblaze, Inc. (BLZE) Just Flashed Golden Cross Signal: Do You Buy? — Positive
BLZE Zacks Investment Research — August 25, 2025Backblaze, Inc. (BLZE) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, BLZE's 50-day simple moving average crossed above its 200-day simple moving average, known as a "golden cross.
Wall Street Analysts Believe Superior Group (SGC) Could Rally 38.36%: Here's is How to Trade — Positive
SGC Zacks Investment Research — August 25, 2025The average of price targets set by Wall Street analysts indicates a potential upside of 38.4% in Superior Group (SGC). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Wall Street Analysts Believe Remitly Global (RELY) Could Rally 42.31%: Here's is How to Trade — Positive
RELY Zacks Investment Research — August 25, 2025The mean of analysts' price targets for Remitly Global (RELY) points to a 42.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Does Thryv (THRY) Have the Potential to Rally 55.07% as Wall Street Analysts Expect? — Positive
THRY Zacks Investment Research — August 25, 2025The consensus price target hints at a 55.1% upside potential for Thryv (THRY). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
SiteOne Landscape (SITE)'s Technical Outlook is Bright After Key Golden Cross — Positive
SITE Zacks Investment Research — August 25, 2025From a technical perspective, SiteOne Landscape Supply, Inc. (SITE) is looking like an interesting pick, as it just reached a key level of support. SITE's 50-day simple moving average crossed above its 200-day simple moving average, which is known as a "golden cross" in the trading world.
Wall Street Analysts Believe Great Lakes Dredge & Dock (GLDD) Could Rally 25.84%: Here's is How to Trade — Positive
GLDD Zacks Investment Research — August 25, 2025The mean of analysts' price targets for Great Lakes Dredge & Dock (GLDD) points to a 25.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Should You Buy Aveanna Healthcare (AVAH) After Golden Cross? — Positive
AVAH Zacks Investment Research — August 25, 2025Aveanna Healthcare Holdings Inc. (AVAH) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, AVAH's 50-day simple moving average crossed above its 200-day simple moving average, known as a "golden cross.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALT — Neutral
ALT GlobeNewsWire — August 25, 2025NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Altimmune, Inc. (“Altimmune” or the “Company”) (NASDAQ: ALT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
All of us could use a little more monthly income; it's not just for retired folks anymore.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadlines - NVO — Neutral
NVO GlobeNewsWire — August 25, 2025NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Novo Nordisk A/S (“Novo Nordisk” or the “Company”) (NYSE: NVO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Sable Offshore Corp. of Class Action Lawsuit and Upcoming Deadlines - SOC — Neutral
SOC GlobeNewsWire — August 25, 2025NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Sable Offshore Corp. (“Sable” or the “Company”) (NYSE: SOC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.